Loading…
Panchsheel Organics (BSE 531726)₹106.71+0.65%Pharmaceuticals
In the Mar 2026 quarter (standalone), Panchsheel Organics reported sales of ₹31.01 Cr, up 9.5% from Mar 2025, and net profit of ₹1.69 Cr, down 46.5% year on year. For the year to Mar 2026, sales were ₹107 Cr and net profit ₹10.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 24.59 | 23.66 | 25.55 | 31.19 | 26.00 | 27.11 | 26.19 | 28.32 | 23.51 | 25.25 | 26.66 | 31.01 |
| Expenses | 19.82 | 19.34 | 20.78 | 26.60 | 21.68 | 22.11 | 21.77 | 23.68 | 19.87 | 21.90 | 23.02 | 28.73 |
| Operating Profit | 4.87 | 4.42 | 4.90 | 4.72 | 4.42 | 5.12 | 4.53 | 4.76 | 3.74 | 3.49 | 3.77 | 2.42 |
| OPM % | 19.8% | 18.7% | 19.1% | 15.1% | 17.0% | 18.8% | 17.3% | 16.7% | 15.9% | 13.8% | 14.1% | 7.8% |
| Other Income | 0.09 | 1.00 | 1.21 | 0.12 | 0.73 | 0.69 | 0.95 | 0.00 | 0.65 | 0.63 | 1.05 | 1.24 |
| Interest | 0.06 | 0.10 | 0.04 | 0.04 | 0.05 | 0.13 | 0.07 | 0.08 | 0.05 | 0.07 | 0.08 | 0.03 |
| Depreciation | 0.37 | 0.40 | 0.38 | 0.55 | 0.53 | 0.55 | 0.57 | 0.50 | 0.55 | 0.57 | 0.59 | 0.58 |
| Profit before tax | 4.52 | 4.93 | 5.70 | 4.24 | 4.56 | 5.12 | 4.83 | 4.18 | 3.78 | 3.49 | 4.14 | 3.04 |
| Tax % | 25.2% | 25.2% | 25.1% | 34.5% | 24.9% | 26.1% | 24.1% | 23.9% | 25.0% | 24.9% | 11.3% | 43.9% |
| Net Profit | 3.38 | 3.68 | 4.27 | 2.77 | 3.44 | 3.78 | 3.68 | 3.16 | 2.84 | 2.62 | 3.67 | 1.69 |
| EPS (Rs) | 2.87 | 3.14 | 3.61 | 2.12 | 2.59 | 2.87 | 2.80 | 2.42 | 2.17 | 1.97 | 2.78 | 1.30 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39.95 | 39.93 | 41.89 | 47.93 | 49.91 | 48.94 | 68.88 | 103 | 105 | 107 | 107 | 106 |
| Expenses | 34.08 | 33.10 | 35.10 | 41.13 | 42.11 | 41.11 | 56.16 | 83.25 | 86.19 | 90.32 | 93.30 | 93.52 |
| Operating Profit | 5.99 | 6.99 | 6.98 | 6.99 | 8.98 | 8.99 | 12.98 | 19.96 | 18.98 | 17.97 | 13.97 | 13.42 |
| OPM % | 14.0% | 17.0% | 16.0% | 14.0% | 17.0% | 18.0% | 19.0% | 18.9% | 18.0% | 15.9% | 13.0% | 12.6% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 1.99 | 2.99 | 3.99 | 3.57 |
| Interest | 0.99 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.23 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 1.99 | 2.29 |
| Profit before tax | 3.99 | 4.99 | 4.99 | 5.99 | 6.99 | 6.99 | 10.99 | 18.99 | 18.98 | 18.01 | 13.99 | 14.45 |
| Tax % | 27.0% | 36.0% | 29.0% | 29.0% | 28.0% | 31.0% | 26.9% | 26.0% | 27.0% | 24.0% | 24.9% | — |
| Net Profit | 2.99 | 3.01 | 3.99 | 3.99 | 5.01 | 5.01 | 8.01 | 13.99 | 13.99 | 13.99 | 10.99 | 10.82 |
| EPS (Rs) | 3.03 | 3.20 | 3.66 | 4.03 | 5.30 | 5.02 | 8.34 | 11.93 | 10.72 | 10.48 | 8.23 | 8.22 |
| Dividend payout % | 16.9% | 15.9% | 14.0% | 12.0% | 0.0% | 19.9% | 18.0% | 7.0% | 7.0% | 7.9% | 9.9% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 10.01 | 12.01 | 13.02 | 13.02 | 13.02 |
| Reserves | 12.98 | 15.96 | 18.96 | 21.97 | 24.96 | 29.94 | 34.91 | 36.92 | 83.85 | 112 | 121 | 128 |
| Borrowings | 7.01 | 5.01 | 7.01 | 6.01 | 5.01 | 4.01 | 4.01 | 4.01 | 6.01 | 6.01 | 5.01 | 6.01 |
| Other Liabilities | 8.01 | 11.02 | 9.00 | 12.00 | 9.00 | 12.01 | 14.03 | 22.08 | 21.07 | 28.14 | 24.12 | 25.12 |
| Total Liabilities | 33.01 | 37.00 | 38.98 | 43.99 | 43.98 | 51.97 | 57.96 | 74.02 | 123 | 159 | 163 | 172 |
| Fixed Assets | 6.98 | 6.98 | 7.98 | 6.99 | 6.98 | 5.99 | 6.98 | 6.99 | 7.98 | 13.96 | 17.94 | 19.94 |
| CWIP | 0.00 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 3.99 | 5.99 | 14.99 | 16.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | 0.00 | 0.00 |
| Other Assets | 26.03 | 28.03 | 30.01 | 36.01 | 36.01 | 43.99 | 48.99 | 65.04 | 111 | 137 | 131 | 135 |
| Inventories | 9.91 | 11.57 | 12.52 | 13.68 | 14.47 | 15.42 | 18.72 | 25.15 | 32.31 | 39.37 | 45.71 | 44.91 |
| Trade receivables | 13.91 | 14.66 | 15.11 | 19.73 | 18.15 | 22.58 | 19.03 | 32.61 | 38.90 | 39.61 | 34.93 | 39.38 |
| Cash & equivalents | 1.41 | 0.76 | 0.40 | 0.36 | 0.59 | 1.64 | 4.44 | 2.05 | 3.70 | 22.04 | 4.40 | 3.82 |
| Total Assets | 33.01 | 37.00 | 38.98 | 43.99 | 43.98 | 51.97 | 57.96 | 74.02 | 123 | 159 | 163 | 172 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.99 | 2.99 | 0.99 | 2.99 | 1.99 | 4.99 | 4.99 | −1.99 | 0.00 | 9.99 | 3.99 | 9.99 |
| Cash from investing activity | −0.99 | −1.99 | −1.99 | −0.99 | −0.99 | −1.99 | −0.99 | 0.00 | −33.99 | −6.99 | −15.99 | −6.99 |
| Cash from financing activity | 0.00 | −0.99 | 0.99 | −1.99 | −1.99 | −0.99 | −1.99 | −0.99 | 35.94 | 15.99 | −4.99 | −3.99 |
| Net cash flow | 0.00 | −1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 3.01 | −2.01 | 1.01 | 18.04 | −18.03 | −1.01 |
| Capex | 1.25 | 1.63 | 1.90 | 0.81 | 1.01 | 0.50 | 1.80 | 1.54 | 3.96 | 9.90 | 15.57 | 6.92 |
| Free cash flow | 0.00 | 0.00 | −0.99 | 1.99 | 0.99 | 3.99 | 2.99 | −2.99 | −3.99 | 0.00 | −11.97 | 2.99 |
| CFO / OP % | 46.0% | 69.1% | 45.0% | 79.1% | 63.1% | 73.1% | 85.1% | 5.0% | 28.1% | 82.0% | 48.0% | 103.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 142 | 134 | 138 | 170 | 137 | 164 | 140 | 172 | 137 | 137 | 119 | 134 |
| Inventory days | 153 | 154 | 184 | 184 | 163 | 185 | 245 | 236 | 180 | 210 | 245 | 229 |
| Days payable | 80 | 109 | 83 | 124 | 73 | 111 | 152 | 158 | 89 | 114 | 88 | 90 |
| Cash conversion cycle | 215 | 180 | 239 | 230 | 228 | 238 | 234 | 250 | 229 | 233 | 275 | 273 |
| Working capital days | 136 | 138 | 137 | 150 | 155 | 170 | 167 | 192 | 173 | 178 | 204 | 203 |
| ROCE % | 14.0% | 19.0% | 20.0% | 18.1% | 18.0% | 20.0% | 19.0% | 25.0% | 26.0% | 17.0% | 14.0% | 10.0% |
For the Mar 2026 quarter, Panchsheel Organics reported sales of ₹31.01 Cr, up 9.5% year on year and net profit of ₹1.69 Cr, down 46.5% year on year. The operating margin was 7.8%.
Panchsheel Organics' sales for the year to Mar 2026 were ₹107 Cr; over the last twelve months they were ₹106 Cr.
Net profit for the year to Mar 2026 was ₹10.99 Cr, and ₹10.82 Cr over the last twelve months. Earnings per share over the same trailing period were ₹8.22.
Panchsheel Organics reported borrowings of ₹6.01 Cr at Mar 2026, against cash and equivalents of ₹3.82 Cr.
Cash from operations was ₹9.99 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹2.99 Cr.